Radiation-Sensitizing Agents
"Radiation-Sensitizing Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells.
| Descriptor ID |
D011838
|
| MeSH Number(s) |
D27.505.954.600
|
| Concept/Terms |
Radiation-Sensitizing Agents- Radiation-Sensitizing Agents
- Radiation Sensitizers
- Sensitizers, Radiation
- Radiation Sensitizing Agents
- Sensitizing Agents, Radiation
- Radiosensitizing Agents
- Agents, Radiosensitizing
- Radiosensitizing Drugs
- Drugs, Radiosensitizing
- Agents, Radiation-Sensitizing
- Agents, Radiation Sensitizing
- Radiation-Sensitizing Drugs
- Drugs, Radiation-Sensitizing
- Radiation Sensitizing Drugs
Radiation-Sensitizing Effect- Radiation-Sensitizing Effect
- Effect, Radiation-Sensitizing
- Radiation Sensitizing Effect
- Radiosensitizing Effect
- Effect, Radiosensitizing
- Radiosensitizing Effects
- Effects, Radiosensitizing
- Radiation-Sensitizing Effects
- Effects, Radiation-Sensitizing
- Radiation Sensitizing Effects
|
Below are MeSH descriptors whose meaning is more general than "Radiation-Sensitizing Agents".
Below are MeSH descriptors whose meaning is more specific than "Radiation-Sensitizing Agents".
This graph shows the total number of publications written about "Radiation-Sensitizing Agents" by people in this website by year, and whether "Radiation-Sensitizing Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Radiation-Sensitizing Agents" by people in Profiles.
-
Radiosensitizing effect of anti-HER2/neu agents: Report of 2 cases and review of the literature. Pract Radiat Oncol. 2015 Mar-Apr; 5(2):e61-5.
-
A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade? Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation. Ann Oncol. 2013 Mar; 24(3):769-76.